Moneycontrol PRO
HomeNewsBusinessMarketsHere’s why Prakash Diwan is upbeat on Biocon, Delta Corp

Here’s why Prakash Diwan is upbeat on Biocon, Delta Corp

the fact that Biocon has got approval for Insulin Glargine form EU Commission & the Australian regulator will help them consolidate their position & market share in this space, said Prakash Diwan.

March 28, 2018 / 16:53 IST

Market expert Prakash Diwan in an interview to CNBC-TV18 shared his outlook on the market and specific stocks/sectors.

Talking about the pharma space he said it is a bit early for it to start giving a secular uptrend. “It has still got room before the consolidated phase gets over and we see some incremental institutional buying,” he said, adding that right now one could see some nibbling happening in the space.

On Biocon, he said the fact that the company has got approval for Insulin Glargine form EU Commission and the Australian regulator will help them consolidate their position and market share in this space. “As the economies of scale come up and geographies increase, it will start becoming EPS accretive,” he said, adding that good to buy the stock.

He also spoke about the rationale for being bullish on Delta Corp.

Weak global cues and expiry day jitters play spoilsport on Dalal Street with the Sensex going below 33,000 in the March series and both Sensex and Nifty losing over 2 percent.

Diwan said maybe the April series could start on a better note because the rollovers have been mostly on the long side in some of the active counters. The close of March series may not determine the course for April series, he said.

CNBC-TV18
first published: Mar 28, 2018 04:34 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347